Abstract:Genetically engineered mouse models (GEMMs) are important immunocompetent models for research into the roles of individual genes in cancer and the development of novel therapies. Here we use inducible CRISPR-Cas9 systems to develop two GEMMs which aim to model the extensive chromosome p3 deletion frequently observed in clear cell renal cell carcinoma (ccRCC). We cloned paired guide RNAs targeting early exons of Bap1, Pbrm1, and Setd2 in a construct containing a Cas9D10A (nickase, hSpCsn1n) driven by tetracycline (tet)-responsive elements (TRE3G) to develop our first GEMM. The founder mouse was crossed with two previously established transgenic lines, one carrying the tet-transactivator (tTA, Tet-Off) and one with a triple-mutant stabilized HIF1A-M3 (TRAnsgenic Cancer of the Kidney, TRACK), both driven by a truncated, proximal tubule-specific γ-glutamyltransferase 1 (ggt or γGT) promoter, to create triple-transgenic animals. Our results indicate that this model (BPS-TA) induces low numbers of somatic mutations in Bap1 and Pbrm1 (but not in Setd2), known tumor suppressor genes in human ccRCC. These mutations, largely restricted to kidneys and testis, induced no detectable tissue transformation in a cohort of 13 month old mice (N = 10). To gain insights into the low frequencies of insertions and deletions (indels) in BPS-TA mice we analyzed wild type (WT, N = 7) and BPS-TA (N = 4) kidneys by RNAseq. This showed activation of both DNA damage and immune response, suggesting activation of tumor suppressive mechanisms in response to genome editing. We then modified our approach by generating a second model in which a ggt-driven, cre-regulated Cas9WT(hSpCsn1) was employed to introduce Bap1, Pbrm1, and Setd2 genome edits in the TRACK line (BPS-Cre). The BPS-TA and BPS-Cre lines are both tightly controlled in a spatiotemporal manner with doxycycline (dox) and tamoxifen (tam), respectively. In addition, whereas the BPS-TA line relies on paired guide RNAs (gRNAs), the BPS-Cre line requires only single gRNAs for gene perturbation. In the BPS-Cre we identified increased Pbrm1 gene-editing frequencies compared to the BPS-TA model. Whereas we did not detect Setd2 edits in the BPS-TA kidneys, we found extensive editing of Setd2 in the BPS-Cre model. Bap1 editing efficiencies were comparable between the two models. Although no gross malignancies were observed in our study, this is the first reported GEMM which models the extensive chromosome 3p deletion frequently observed in kidney cancer patients. Further studies are required (1) to model more extensive 3p deletions, e.g. impacting additional genes, and (2) to increase the cellular resolution, e.g. by employing single-cell RNAseq to ascertain the effects of specific combinatorial gene inactivation.

Mice with renal-specific alterations of stem cell-associated signaling develop symptoms of chronic kidney disease but surprisingly no tumors

Induction of transplantable mouse renal cell cancers by streptozotocin: in vivo growth, metastases, and angiogenic phenotype

Disruption of Tubular Flcn Expression As a Mouse Model for Renal Tumor Induction.

Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients

Single cell analysis of the developing mouse kidney provides deeper insight into marker gene expression and ligand-receptor crosstalk

Single-cell transcriptome atlas in C57BL/6 mice encodes morphological phenotypes in the aging kidneys

New Mouse Model of Chronic Kidney Disease Transitioned from Ischemic Acute Kidney Injury

Brown-Norway Chromosome 1 Mitigates the Upregulation of Proinflammatory Pathways in Mtal Cells and Subsequent Age-Related CKD in Dahl SS/JrHsdMcwi Rats.

β-Catenin in the kidney stroma modulates pathways and genes to regulate kidney development

Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease

Glomerulocystic Kidney Disease in Mice with A Targeted Inactivation of Wwtr1

Novel genetically engineered mouse models for clear cell renal cell carcinoma

Renal Gene and Protein Expression Signatures for Prediction of Kidney Disease Progression

Kidney organoids are capable of forming tumors, but not teratomas

Single cell regulatory landscape of the mouse kidney highlights cellular differentiation programs and disease targets

Shared and distinct renal transcriptome signatures in three standard mouse models of chronic kidney disease

Conditional Myh9 and Myh10 inactivation in adult mouse renal epithelium results in progressive kidney disease

Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned

Single-Cell multiomics reveals ENL mutation perturbs kidney developmental trajectory by rewiring gene regulatory landscape

Mouse embryonic kidney transplantation identifies maturation defects in the medulla

Flcn-deficient Renal Cells Are Tumorigenic and Sensitive to Mtor Suppression